Provided by Tiger Trade Technology Pte. Ltd.

Arvinas Holding Company LLC

7.43
-0.3050-3.94%
Post-market: 7.480.0500+0.67%19:55 EDT
Volume:807.32K
Turnover:6.08M
Market Cap:485.82M
PE:55.58
High:7.82
Open:7.74
Low:7.43
Close:7.74
52wk High:14.51
52wk Low:6.97
Shares:65.39M
Float Shares:56.67M
Volume Ratio:1.01
T/O Rate:1.42%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.1337
EPS(LYR):-1.1400
ROE:1.59%
ROA:-1.01%
PB:0.86
PE(LYR):-6.52

Loading ...

Arvinas Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 12

BUZZ-U.S. STOCKS ON THE MOVE-Under Armour, C3 AI, Rigel Pharma

Reuters
·
May 12

Arvinas Grants Rigel Global Rights to VEPPANU Therapy

TIPRANKS
·
May 12

Arvinas publishes corporate presentation on PROTAC protein degraders in cancer, neurodegenerative diseases

Reuters
·
May 12

Arvinas, Pfizer Tap Rigel Pharmaceuticals to Bring Veppanu to Market

Dow Jones
·
May 12

Arvinas Q1 sales miss estimates on lower collaboration revenue from Pfizer

Reuters
·
May 12

Arvinas Q1 EPS $(0.90) Misses $(0.87) Estimate, Sales $15.600M Miss $18.097M Estimate

Benzinga Earnings
·
May 12

BRIEF-Arvinas Q1 Operating Expenses USD 79.4 Million

Reuters
·
May 12

Arvinas Reports First Quarter 2026 Financial Results and Provides Corporate Update

THOMSON REUTERS
·
May 12

Arvinas Q1 Basic EPS USD -0.9

THOMSON REUTERS
·
May 12

Arvinas Q1 Net Income USD -57.6 Million VS. Ibes Estimate USD -61.5 Million

THOMSON REUTERS
·
May 12

Rigel licenses breast cancer drug VEPPANU from Arvinas, Pfizer for USD 70 million

Reuters
·
May 12

Arvinas Inc - and Pfizer to Receive $85 Mln in Upfront and Transition Payments

THOMSON REUTERS
·
May 12

Arvinas Inc - and Pfizer Eligible for up to $320 Mln in Milestone Payments and Tiered Royalties

THOMSON REUTERS
·
May 12

Arvinas and Pfizer Enter Into a Transaction With Rigel Pharmaceuticals for the Exclusive Global Rights of Veppanu (Vepdegestrant)

THOMSON REUTERS
·
May 12

Arvinas and Pfizer Enter into a Transaction with Rigel Pharmaceuticals for the Exclusive Global Rights of VEPPANU (vepdegestrant)

GlobeNewswire
·
May 12

Arvinas Q1 net loss widens to $57.6 million; revenue drops 91.74% to $15.6 million

Reuters
·
May 12

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 11

Arvinas Inc expected to post a loss of 92 cents a share - Earnings Preview

Reuters
·
May 08

Arvinas to webcast first-quarter 2026 results, corporate update

Reuters
·
May 05